Pyxis Oncology
Michiel Meerleveld is an experienced Accounts Payable Specialist with a robust background in managing financial processes across various companies. Currently serving at Pyxis Oncology since July 2022, Michiel previously held the same position at Moelis & Company and Alyvant, Inc., where responsibilities included supporting system transitions, invoicing, vendor management, and payment processing. Prior experience includes a role as Accounts Payable Manager at PineBridge Investments, where Michiel oversaw full-cycle accounts payable and inter-company transactions. Additional experience encompasses financial analysis as a Research Analyst at The Wall Street Analyzer, and several finance-related roles including Treasurer for Atletiek Vereniging Nijkerk and Database Analyst at Rabobank International. Michiel holds a degree from Amsterdam University of Applied Sciences.
This person is not in any offices
Pyxis Oncology
2 followers
Pyxis Oncology is advancing a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to help patients suffering from difficult-to-treat cancers.